A trial of Itraconazole or Amphotericin B HIV-associated talaromycosis

<h4>Background</h4> <p>Talaromyces marneffei infection is a major cause of HIV-related death in South and Southeast Asia. Guidelines recommend initial treatment with amphotericin B deoxycholate but it has significant side effects, high cost and limited availability. Itraconazole i...

Description complète

Détails bibliographiques
Auteurs principaux:	Le, T, Kinh, N, Cuc, N, Tung, N, Lam, N, Thuy, P, Cuong, D, Phuc, P, Vinh, V, Hanh, D, Tam, V, Thanh, N, Thuy, T, Hang, N, Long, H, Nhan, H, Wertheim, H, Merson, L, Shikuma, C, Day, J, Chau, N, Farrar, J, Thwaites, J, Wolbers, M
Format:	Journal article
Publié:	Massachusetts Medical Society 2017

A trial of Itraconazole or Amphotericin B HIV-associated talaromycosis

Documents similaires